Shanghai Chicmax Cosmetic Inkomsten in het verleden
Verleden criteriumcontroles 6/6
Shanghai Chicmax Cosmetic has been growing earnings at an average annual rate of 34.5%, while the Personal Products industry saw earnings growing at 10% annually. Revenues have been growing at an average rate of 103.6% per year. Shanghai Chicmax Cosmetic's return on equity is 36.4%, and it has net margins of 12.5%.
Belangrijke informatie
34.5%
Groei van de winst
31.6%
Groei van de winst per aandeel
Personal Products Groei van de industrie | 8.8% |
Inkomstengroei | 103.6% |
Rendement op eigen vermogen | 36.4% |
Nettomarge | 12.5% |
Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Shanghai Chicmax Cosmetic geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Jun 24 | 6,106 | 761 | 3,622 | 150 |
31 Mar 24 | 5,149 | 611 | 3,028 | 138 |
31 Dec 23 | 4,191 | 461 | 2,435 | 126 |
30 Sep 23 | 3,595 | 322 | 2,082 | 119 |
30 Jun 23 | 3,000 | 183 | 1,730 | 113 |
31 Mar 23 | 2,838 | 165 | 1,611 | 112 |
31 Dec 22 | 2,675 | 147 | 1,493 | 110 |
30 Sep 22 | 2,862 | 188 | 1,562 | 109 |
30 Jun 22 | 3,050 | 230 | 1,631 | 107 |
31 Mar 22 | 3,334 | 284 | 1,736 | 106 |
31 Dec 21 | 3,619 | 339 | 1,840 | 105 |
31 Dec 20 | 3,382 | 203 | 1,800 | 77 |
31 Dec 19 | 2,874 | 63 | 1,550 | 83 |
Kwaliteitswinsten: 2145 has high quality earnings.
Groeiende winstmarge: 2145's current net profit margins (12.5%) are higher than last year (6.1%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 2145's earnings have grown significantly by 34.5% per year over the past 5 years.
Versnelling van de groei: 2145's earnings growth over the past year (316.6%) exceeds its 5-year average (34.5% per year).
Winst versus industrie: 2145 earnings growth over the past year (316.6%) exceeded the Personal Products industry 48.8%.
Rendement op eigen vermogen
Hoge ROE: 2145's Return on Equity (36.4%) is considered high.